Literature DB >> 27047953

Radiotherapy: killing with complement.

Jean F Regal1, Kenneth J Dornfeld1, Sherry D Fleming1.   

Abstract

Year:  2016        PMID: 27047953      PMCID: PMC4791333          DOI: 10.21037/atm.2015.12.46

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  26 in total

Review 1.  Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth.

Authors:  Liam G Coulthard; Trent M Woodruff
Journal:  J Immunol       Date:  2015-04-15       Impact factor: 5.422

2.  Axitinib sensitization of high Single Dose Radiotherapy.

Authors:  Shyam S Rao; Chris Thompson; Jin Cheng; Adriana Haimovitz-Friedman; Simon N Powell; Zvi Fuks; Richard N Kolesnick
Journal:  Radiother Oncol       Date:  2014-04-29       Impact factor: 6.280

3.  C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.

Authors:  Nien-Jung Chen; Christine Mirtsos; Daniel Suh; Yong-Chen Lu; Wen-Jye Lin; Colin McKerlie; Taeweon Lee; Helene Baribault; Hui Tian; Wen-Chen Yeh
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

4.  Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.

Authors:  Laura Surace; Veronika Lysenko; Andrea Orlando Fontana; Virginia Cecconi; Hans Janssen; Antonela Bicvic; Michal Okoniewski; Martin Pruschy; Reinhard Dummer; Jacques Neefjes; Alexander Knuth; Anurag Gupta; Maries van den Broek
Journal:  Immunity       Date:  2015-04-14       Impact factor: 31.745

5.  Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.

Authors:  Q Ma; D Li; R Carreño; R Patenia; K Y Tsai; M Xydes-Smith; A M Alousi; R E Champlin; G E Sale; V Afshar-Kharghan
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

6.  Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience.

Authors:  Melva E Pinn; Douglas G Gold; Ivy A Petersen; Thomas G Osborn; Paul D Brown; Robert C Miller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

7.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

8.  The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.

Authors:  Claire E Bamberg; Charles R Mackay; Hyun Lee; David Zahra; Jenny Jackson; Yun Si Lim; Peter L Whitfeld; Stewart Craig; Erin Corsini; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  The human complement fragment receptor, C5L2, is a recycling decoy receptor.

Authors:  Anne-Marie Scola; Kay-Ole Johswich; B Paul Morgan; Andreas Klos; Peter N Monk
Journal:  Mol Immunol       Date:  2008-12-18       Impact factor: 4.407

View more
  2 in total

1.  White Matter is the Predilection Site of Late-Delayed Radiation-Induced Brain Injury in Non-Human Primates.

Authors:  Rachel N Andrews; Gregory O Dugan; Ann M Peiffer; Gregory A Hawkins; David B Hanbury; J Daniel Bourland; Robert E Hampson; Samuel A Deadwyler; J Mark Clinea
Journal:  Radiat Res       Date:  2019-01-29       Impact factor: 2.841

Review 2.  Clinical Translation of Neutrophil Imaging and Its Role in Cancer.

Authors:  Doreen Lau; Laura M Lechermann; Ferdia A Gallagher
Journal:  Mol Imaging Biol       Date:  2021-10-12       Impact factor: 3.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.